CTi Biopharma Corp

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. Show More...

Website https://www.ctibiopharma.com
Sector Healthcare
Industry Biotechnology
Last Quote 9.09 USD
Last Updated 26-06-2023
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2010-12	2011-12	2012-12	2013-12	2014-12	2015-12	2016-12	2017-12	2018-12	2019-12	TTM
Earnings Per Share USD	-64.7	-35.3	-19.8	-4.3	-6.46	-6.51	-1.86	-1.24	-0.52	-0.69	-0.7
Dividends USD
Payout Ratio % *
Shares Mil	2.0	3.0	6.0	11.0	15.0	19.0	28.0	36.0	56.0	58.0	59.0
Book Value Per Share * USD	-1.75	3.97	3.15	0.17	1.07	-0.83	0.63	0.77	0.98	0.55	0.38
Free Cash Flow Per Share * USD	-28.54	-22.54	-11.31	-6.22	-2.39	-4.03	-3.17	-1.33	-0.72	-0.5
Return on Assets %	-239.57	-209.06	-169.58	-59.3	-103.21	-103.65	-49.97	-75.84	-40.63	-58.8	-50.56
Financial Leverage (Average)		2.83	2.13	2.07	2.21	2.77	4.79	2.65	1.53	1.95	3.13
Return on Equity %			-407.81	-124.54	-220.85	-261.49	-159.17	-264.5	-74.04	-97.16	-105.48
Return on Invested Capital %			-407.62	-90.47	-158.68	-143.19	-69.64	-127.7	-53.73	-72.97	-76.9
Interest Coverage	-32.03	-59.33		-27.3	-34.21	-47.42	-17.72	-19.06	-15.93	-25.28	-28.65
Current Ratio	0.66	2.87	2.66	4.01	2.22	1.86	1.37	2.44	3.58	1.92	5.74
Quick Ratio	0.55	2.65	2.23	3.58	2.01	1.77	1.28	1.48	3.5	1.82	5.63
Debt/Equity				0.22	0.2	0.37	0.85	0.66	0.16	0.31	0.2

CTi Biopharma Corp

Interest Coverage